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Background: CD31 identifies a heterogeneous population of cells in the blood, including endothelial cells, progenitor cells, and mature 
hematopoietic cells. Unfractionated CD31+ blood cells have demonstrated in vitro and in vivo angiogenic properties. However, the association of 
CD31+ blood cells with cardiovascular risk in healthy individuals has not been investigated.
Methods: We studied 1,523 participants (mean age 65±9 years, 56% women) from the Framingham Offspring Study, free of prevalent 
cardiovascular disease, who underwent CD31+ cell phenotyping. Using anti-human CD31 and CD45 antibodies, distinct CD31+ cell populations 
were enumerated in blood samples by FACS analysis. We used linear regression analyses to investigate the relation of each cell phenotype with 
cardiovascular risk factors.
Results: We analyzed 3 distinct leukocyte populations: CD31-, CD31dim, and CD31bright cells. Using forward and side scatter analyses, CD31- and 
CD31dim cells mapped to a highly enriched lymphoid gate while CD31bright cells were composed of enriched monocytes. Given the prominent 
role of monocytes in cardiovascular disease, we first analyzed this population. In multivariable analyses, higher frequency of CD31bright cells was 
associated with older age (P<0.001), male sex (P<0.001), hsCRP (P<0.001) and Framingham risk score (FRS, P=0.003). In contrast, CD31dim cell 
frequency inversely correlated with age (P<0.001), male sex (P<0.001), hsCRP (P<0.01), smoking (P<0.001) and FRS (P=0.03).
Conclusions: We present the first analysis of circulating CD31+ cells in relation to cardiovascular risk in a large community-based cohort. We 
identified 2 major CD31+ leukocyte populations (CD31bright and CD31dim cells) with differing forward/side scatter characteristics. Interestingly, 
these cell populations were oppositely associated with cardiovascular risk, demonstrating significant heterogeneity within circulating CD31+ cells. 
These results support efforts to further define the biological roles of angiogenic CD31+ cells in vascular disease.
